Ovarian cancer cisplatin-resistant cell lines: Multiple changes including collateral sensitivity to Taxol
Open Access
- 1 April 1998
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (4) , 423-430
- https://doi.org/10.1023/a:1008265012435
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell linesApoptosis, 1997
- The role of the glutathione-dependent system in tumor sensitivity to cisplatin: A study of human tumor xenograftsAnnals of Oncology, 1995
- Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor typesAnti-Cancer Drugs, 1994
- Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesBritish Journal of Cancer, 1992
- The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell linesBritish Journal of Cancer, 1991
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.Proceedings of the National Academy of Sciences, 1987
- Binding of cis - and trans -dichlorodiammineplatinum(II) to the nucleosome coreProceedings of the National Academy of Sciences, 1979
- A RAPID BANDING TECHNIQUE FOR HUMAN CHROMOSOMESThe Lancet, 1971
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959